


Vicarius Pharma
Pharmaceutical Manufacturing • Küssnacht am Rigi, Schwyz, Switzerland • 1-10 Employees
Company overview
| Headquarters | Bodenstrasse 23, Kuessnacht, 6403, CH |
| Phone number | +41418522244 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Biopharmaceuticals, Rare Diseases, Regulatory Strategy, Market Access Strategy, European Commercialization |
| Founded | 2016 |
| Employees | 1-10 |
| Socials |
Key Contact at Vicarius Pharma
Barbara Briggs
Senior Director Regulatory Affairs
About Vicarius Pharma
Vicarius Pharma bridges the gap between traditional go-it-alone and out-licensing entry strategies for Europe. Vicarius is the partner of choice for non-European companies seeking to commercialize their first product across Europe without having to out-license to a larger pharmaceutical partner or build their own commercial organization overseas. We are launch experts with unmatched experience and a deep understanding of the European markets. We work as our partners’ European go-to-market organization. We commercialize their assets in Europe, providing strategic advice on regulatory, pricing and commercial strategy, holding the marketing authorization and taking legal and operational responsibility for the asset in Europe. Vicarius’ business model is particularly attractive for companies with specialty, rare disease and hospital products. Vicarius Pharma is based in Switzerland.
Vicarius Pharma revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $273,776 |
| Total funding | $21,600,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Frequently asked questions
4.8
40,000 users



